Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study

被引:0
|
作者
Sana, Adama [1 ]
Djemai, Elodie [2 ]
De Vreyer, Philippe [2 ]
Thivillon, Thomas [3 ]
Badolo, Hermann [4 ]
Berthe, Abdramane [5 ,6 ]
Kania, Dramane [6 ]
机构
[1] Ctr Natl Rech Sci & Technol CNRST, Inst Rech Sci Sante IRSS, Dept Biomed & Sante Publ, Ouagadougou, Burkina Faso
[2] Univ PSL, Univ Paris Dauphine, LEDa, CNRS,IRD,DIAL, Paris, France
[3] Univ Bordeaux, UMR, Bordeaux Sci Econ, CNRS 6060, Pessac, France
[4] Inst Natl Sante Publ, Observ Natl Sante Populat, Ouagadougou, Burkina Faso
[5] Univ Dedougou, Dedougou, Burkina Faso
[6] Inst Natl Sante Publ, Ctr Muraz, Bobo Dioulasso, Burkina Faso
来源
PLOS ONE | 2024年 / 19卷 / 08期
关键词
AFRICAN COUNTRIES; PERFORMANCE; COVID-19;
D O I
10.1371/journal.pone.0305850
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since March 2020, COVID-19 has evolved from a localized outbreak to a global pandemic. We assessed the seroprevalence of COVID-19 in three towns in the Centre Sud region of Burkina Faso.Methods A population-based cross-sectional survey was conducted in three middle-sized cities in Burkina Faso's Centre Sud region, from June to July 2021. Subjects aged 16 or over at the time of the survey were considered for this seroprevalence study. The Biosynex COVID-19 BSS rapid test was used to detect immunoglobulin G (IgG) and immunoglobulin M (IgM) against SARS-CoV-2. A standardized questionnaire was also administered to collect additional information.Results A total of 2449 eligible participants (age >= 16 years) were identified. Serological tests for COVID-19 were performed in 2155 individuals, of which 2143 valid tests were retained and analyzed. Out of the entire sample, 246 positive tests were observed, corresponding to a prevalence of 11.48%. Prevalence was 9.35% (58 cases) in Kombissiri, 12.86% (80 cases) in Manga and 11.99% (108 cases) in P & ocirc;. By gender, 13.37% of women (164 cases) tested positive, and 8.95% of men (82 cases). Women accounted for 66.67% of all positive test subjects. The results from the multivariate analysis show a significantly higher seroprevalence in women (p = 0.007), people over 55 years old (p = 0.004), overweight people (p = 0.026) and those with drinking water sources at home (p = 0.013).Conclusions The results of this study show that the COVID-19 virus also circulates in the population of middle-sized cities in Burkina Faso, far more than officially reported by the information service of the government of Burkina Faso, given the lack of systematic testing in the general population in the country. The study also highlighted the greater vulnerability of women, older and overweight individuals to the epidemic. The preventive measures put in place to fight the pandemic must take these different factors into account.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Taher, Watheq Thabet
    Bawazir, Amen A.
    Sallam, Talal A.
    Alsurimi, Khaled
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [2] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Watheq Thabet Taher
    Amen A. Bawazir
    Talal A. Sallam
    Khaled Alsurimi
    BMC Infectious Diseases, 23
  • [3] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    El-Ghitany, Engy Mohamed
    Hashish, Mona H.
    Farghaly, Azza Galal
    Omran, Eman A.
    Osman, Nermin A.
    Fekry, Marwa M.
    TROPICAL MEDICINE AND HEALTH, 2022, 50 (01)
  • [4] Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
    Engy Mohamed El-Ghitany
    Mona H. Hashish
    Azza Galal Farghaly
    Eman A. Omran
    Nermin A. Osman
    Marwa M. Fekry
    Tropical Medicine and Health, 50
  • [5] Risk factors for SARS-CoV-2 infection in Jordan: A cross-sectional study in the prevaccination period
    Al-Mharmah, Ahmad Ali Qaied
    Ruh, Emrah
    Tosun, Ozgur
    Almomani, Waleed Mahmoud Husein
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (09):
  • [6] SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study
    Sapronova, Krista
    Kake, Ruta
    Pavare, Jana
    Gravele, Dagne
    Sela, Ivita
    Ergle, Estere
    Isarova, Dana
    Grinberga, Zanda
    Zavadska, Dace
    MEDICINE, 2023, 102 (06)
  • [7] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
    Ebinger, Joseph E.
    Botwin, Gregory J.
    Albert, Christine M.
    Alotaibi, Mona
    Arditi, Moshe
    Berg, Anders H.
    Binek, Aleksandra
    Botting, Patrick
    Fert-Bober, Justyna
    Figueiredo, Jane C.
    Grein, Jonathan D.
    Hasan, Wohaib
    Henglin, Mir
    Hussain, Shehnaz K.
    Jain, Mohit
    Joung, Sandy
    Karin, Michael
    Kim, Elizabeth H.
    Li, Dalin
    Liu, Yunxian
    Luong, Eric
    McGovern, Dermot P. B.
    Merchant, Akil
    Merin, Noah
    Miles, Peggy B.
    Minissian, Margo
    Nguyen, Trevor Trung
    Raedschelders, Koen
    Rashid, Mohamad A.
    Riera, Celine E.
    Riggs, Richard, V
    Sharma, Sonia
    Sternbach, Sarah
    Sun, Nancy
    Tourtellotte, Warren G.
    Van Eyk, Jennifer E.
    Sobhani, Kimia
    Braun, Jonathan G.
    Cheng, Susan
    BMJ OPEN, 2021, 11 (02): : e043584
  • [8] Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities
    Malagon-Rojas, Jeadran Nevardo
    Mercado-Reyes, Marcela
    Toloza-Perez, Yezith G.
    Parra Barrera, Eliana L.
    Palma, Marien
    Munoz, Esperanza
    Lopez, Ronald
    Almentero, Julia
    Rubio, Vivian V.
    Ibanez, Edgar
    Tellez, Eliana
    Delgado-Murcia, Lucy G.
    Jimenez, Claudia P.
    Viasus-Perez, Diego
    Galindo, Marisol
    Lagos, Luisa
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2022, 79 (06) : 388 - 395
  • [9] SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study
    Mendiboure, Vincent
    Teiti, Iotefa
    Aubry, Maite
    Teissier, Anita
    Paoaafaite, Tuterarii
    Vanhomwegen, Jessica
    Manuguerra, Jean-Claude
    Fontanet, Arnaud
    Cao-Lormeau, Van-Mai
    Madec, Yoann
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [10] SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study
    Vincent Mendiboure
    Iotefa Teiti
    Maite Aubry
    Anita Teissier
    Tuterarii Paoaafaite
    Jessica Vanhomwegen
    Jean-Claude Manuguerra
    Arnaud Fontanet
    Van-Mai Cao-Lormeau
    Yoann Madec
    BMC Public Health, 24